Statlab Diagnostics, LLC

Statlab Diagnostics, LLC was paid $2.57M by Medicaid between Jan 2021 and Feb 2024, across 15 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 64% of everything it billed.

33Billing provider infoSTATLAB DIAGNOSTICS, LLC
DENVER, CO 80211

33aNPI1790387223assigned 11/10/2020

33bProvider typeClinical Medical Laboratory

28Total paid$2.57M

24GClaims58,935

24DCodes billed15

24AFirst – last monthJan 2021 – Feb 2024

Compared with peers

Next to other Clinical Medical Laboratory providers in Colorado

Rank by total paid#14 of 91

Median peer was paid$53K

This provider vs. median48×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2021	8,832	$297K
2022	41,378	$1.73M
2023	7,751	$486K
2024incomplete	974	$56K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	64%	27,428	10,895	$1.64M
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	11%	1,120	998	$271K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	10%	15,092	7,980	$265K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	6.0%	8,327	2,453	$154K
87481		1.6%	800	727	$41K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	1.3%	1,085	1,045	$33K
87529		1.3%	518	496	$33K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	1.3%	1,095	1,053	$33K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	1.2%	1,095	1,053	$32K
87511		1.1%	878	847	$27K
87640		<1%	587	544	$16K
87653		<1%	517	487	$16K

3 more codes

87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	126	$6K
87641		<1%	148	$4K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	119	$3K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKERMAN, SHIDEH (CEO)

Same official

Other billing entities under KERMAN, SHIDEH

Full network →

Provider	Location	Paid
Urgent Care Solutions Glendale, P.C.	Denver, CO	$5.20M
Urgent Care Solutions Glendale, PC	Denver, CO	$105K
Primary Care Solutions P.C.	Denver, CO	$2K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.